IPL dry eye therapy using FDA-approved Lumenis Stellar M22 to improve meibomian gland function

IPL Dry Eye Therapy

Using the FDA-approved Lumenis Stellar M22 IPL specifically designed for improving signs of dry eye disease, IPL uses pulses of non-laser light applied to the skin around the eyelids. IPL improves meibomian gland function and reduces inflammation on the eyelids and ocular surface, leading to an improvement in tear film stability.

Book a Consultation

Benefits

⚪️ Decrease in evaporative dry eye disease and dry eye symptoms

⚪️ Improved meibomian gland function

⚪️ Reduces rosacea-related ocular inflammation

⚪️ Decreases the occurrence of styes and eyelid inflammation

Results

⚪️ After a series of treatments (usually 4 sessions), patients typically enjoy relief for 8-12 months

Recovery

⚪️ Mild redness or swelling may occur on day one

⚪️ Possible skin sensitivity for a few hours